Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

The lenalidomide/bortezomib/dexamethasone regimen for the treatment of blastic plasmacytoid dendritic cell neoplasm.

Marmouset V, Joris M, Merlusca L, Beaumont M, Charbonnier A, Marolleau JP, Gruson B.

Hematol Oncol. 2019 Oct;37(4):487-489. doi: 10.1002/hon.2671. Epub 2019 Sep 4.

PMID:
31465531
2.

PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells.

Caulier A, Jankovsky N, Demont Y, Ouled-Haddou H, Demagny J, Guitton C, Merlusca L, Lebon D, Vong P, Aubry A, Lahary A, Rose C, Gréaume S, Cardon E, Platon J, Ouadid-Ahidouch H, Rochette J, Marolleau JP, Picard V, Garçon L.

Haematologica. 2020 Mar;105(3):610-622. doi: 10.3324/haematol.2019.218503. Epub 2019 Aug 14.

3.

[Subretinal fluid in acute posterior multifocal placoid pigment epitheliopathy: A case report].

Guedira G, Taright N, Merlusca L, Gourguechon C, Milazzo S.

J Fr Ophtalmol. 2018 Sep;41(7):e303-e305. doi: 10.1016/j.jfo.2017.11.030. Epub 2018 Aug 31. French. No abstract available.

PMID:
30173872
4.

Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study.

Paccou J, Merlusca L, Henry-Desailly I, Parcelier A, Gruson B, Royer B, Charbonnier A, Ursu D, Desailloud R, Garidi R, Kamel S, Sevestre H, Marolleau JP, Fardellone P, Damaj G.

Ann Oncol. 2014 Feb;25(2):481-6. doi: 10.1093/annonc/mdt560. Epub 2014 Jan 8.

5.

L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm.

Gruson B, Vaida I, Merlusca L, Charbonnier A, Parcelier A, Damaj G, Royer B, Marolleau JP.

Br J Haematol. 2013 Nov;163(4):543-5. doi: 10.1111/bjh.12523. Epub 2013 Aug 12. No abstract available.

PMID:
23937331
6.

5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy.

Ivanoff S, Gruson B, Chantepie SP, Lemasle E, Merlusca L, Harrivel V, Charbonnier A, Votte P, Royer B, Marolleau JP.

Am J Hematol. 2013 Jul;88(7):601-5. doi: 10.1002/ajh.23464. Epub 2013 May 30.

7.

Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients.

Royer B, Merlusca L, Abraham J, Musset L, Haroche J, Choquet S, Leleu X, Sebban C, Decaux O, Galicier L, Roussel M, Recher C, Banos A, Guichard I, Brisseau JM, Godmer P, Hermine O, Deplanque G, Facon T, Asli B, Leblond V, Fermand JP, Marolleau JP, Jaccard A.

Am J Hematol. 2013 Mar;88(3):207-12. doi: 10.1002/ajh.23374. Epub 2013 Jan 18.

8.

Bone complications of mastocytosis: a link between clinical and biological characteristics.

Guillaume N, Desoutter J, Chandesris O, Merlusca L, Henry I, Georgin-Lavialle S, Barete S, Hirsch I, Bouredji D, Royer B, Gruson B, Lok C, Sevestre H, Mentaverri R, Brazier M, Meynier J, Hermine O, Marolleau JP, Kamel S, Damaj G.

Am J Med. 2013 Jan;126(1):75.e1-7. doi: 10.1016/j.amjmed.2012.07.018. Epub 2012 Nov 28.

PMID:
23200108
9.

Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy.

Gruson B, Ghomari K, Beaumont M, Garidi R, Just A, Merle P, Merlusca L, Marolleau JP, Royer B.

J Peripher Nerv Syst. 2011 Sep;16(3):180-5. doi: 10.1111/j.1529-8027.2011.00343.x.

PMID:
22003932
10.

Patella plasmacytoma: an unusual localization.

Lebon D, Saidi L, Merlusca L, Leduc F, Royer B.

Am J Hematol. 2011 Jun;86(6):504. doi: 10.1002/ajh.21961. Epub 2011 Apr 20. No abstract available.

Supplemental Content

Loading ...
Support Center